A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of Alabama at Birmingham
Soligenix
Prescient Therapeutics, Ltd.
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Columbia University
SciTech Development, Inc.
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Instituto de Investigación Biomédica de Salamanca